GH1 and carcinoma of esophagus: In the two patients with stomach and oesophageal cancer, the clinical efficacy of ghrelin may be limited, since in patients having had vagotomy ghrelin induced only an increase in GH secretion but not in energy intake (le Roux et al, 2005).